HOME >> BIOLOGY >> NEWS
Investigating antibiotic use in acute care patients

Pigs could be the key to understanding how antibiotic resistant bacteria persist in Intensive Care Units in hospitals.

NSW Department of Primary Industries (NSW DPI) Immunology & Molecular Diagnostic Research Unit Team Leader, Dr James Chin, says it is commonly believed that each time an antibiotic is used only pathogens or disease-causing bacteria will be killed.

"Antibiotic use in hospitals is often perceived to be solely directed against only bad bacteria.

"In reality, antibiotics also act against entire microbial communities, including the good bacteria which can protect patients from pathogenic bacteria.

"Antibiotics do not just eliminate bad bacteria", Dr Chin said. "They also maintain a pool of antibiotic resistance genes within the microbial community of patients treated with antibiotics."

Using pigs as a model, Dr Chin and Dr Toni Chapman at NSW DPIs Elizabeth Macarthur Agricultural Institute have examined how E.coli bacteria a common cause of diarrhoea in pigs and humans - respond to treatment by antibiotics.

Dr Chin told the 2007 Australian Society for Microbiologys annual conference in Adelaide in July that: "The current theory of antibiotic resistance is that the fittest bacteria, that is, those carrying genes for resistance, are the most likely to survive.

"Because antibiotic treatment will never kill all bacteria, bad or good, there will always be a pool of antibiotic resistance bacteria that can potentially transfer resistance to incoming pathogens.

"It is important to identify the antimicrobial resistant gene pool in entire microbial communities before antibiotic treatment.

Dr Chin said this has been tested with E. coli in pigs.

"Our research shows clearly that use of one antibiotic to treat E. coli not only increases resistance against that antibiotic but also increases the carriage of resistance genes against other classes of antibiotics.


'"/>

Contact: Joanne Finlay
joanne.finlay@dpi.nsw.gov.au
61-263-913-171
New South Wales Department of Primary Industries
31-Jul-2007


Page: 1 2

Related biology news :

1. Investigating Life in Extreme Environments report gives hints on facts of life
2. Investigating coral reefs to help understand past and future climate change
3. Investigating the trochus El Dorado
4. Investigating the invisible life in our environment
5. Investigating the Columbia River and Estuary: A primary focus of research
6. Researchers watch antibiotics, bacteria meet at atomic level
7. New way to target and kill antibiotic-resistant bacteria found
8. Research group gets $7 million to pursue new antibiotic agents
9. Insects cultivate antibiotic-producing bacteria in their antennae
10. UBC researchers find new superbug weapon for near-empty antibiotics arsenal
11. Will the plague pathogen become resistant to antibiotics?

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... (PRWEB) , ... February 11, 2020 , ... ... firm, is pleased to announce it achieved its ISO 9001:2015 registration by certification ... preparation for the audits, she reviewed and revised all existing Standard Operating Procedures ...
(Date:2/6/2020)... ... February 06, 2020 , ... ... specializing in complex interventional medical device and pharmaceutical trials, announced that Ms. ... this newly established role, Dorothy oversees the development and execution of regulatory ...
(Date:1/30/2020)... ... , ... Accelera Canada , a full-service firm delivering end-to-end commercialization services ... announce that the company has opened the doors of its first office in Toronto, ... “We are so thrilled to now have all our partners and their highly skilled ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... January 21, 2020 , ... Microbial Discovery Group LLC (MDG) ... Industrial and Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s partners ... over 30 years of sales experience working across multiple different market sectors such ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report from ... the vendor qualification process, a critical element of clinical trial set up and ... the vendor qualification process creates delays in initiation in 7% of clinical trials ...
(Date:1/8/2020)... ... January 08, 2020 , ... Anomet ... achieve specific properties for use in harsh environments inside or outside of the ... to three metals or alloys to achieve specific properties such as corrosion-resistance, biocompatibility, ...
(Date:1/7/2020)... ... , ... Vuja De Sciences (“Vuja De”), a biotechnology startup dedicated to developing ... Chand Khanna, DVM, PhD, DACVIM (Onc), and Dr. Lee Helman, MD, to its Board ... to welcome Chand and Lee as new directors. They will be of great help ...
Breaking Biology Technology:
Cached News: